Trazodone/Gabapentin Fixed Dose Combination Products in Painful Diabetic Neuropathy
Status:
Completed
Trial end date:
2020-06-06
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to collect preliminary information on the effect of
three doses of trazodone/gabapentin FDC products on pain intensity in patients with painful
diabetic neuropathy after 8-week treatment period.